MR-based quantitative imaging biomarkers (QIBs) can provide anatomic and functional measures critical to the successful delivery of precision medicine by informing treatment selection, providing early non-invasive assessment of treatment response, and providing post-treatment surveillance. There are significant barriers, however, to successful implementation of such measures across imaging systems, centers, and time, including the need for phantoms (physical and digital) and standards. This presentation will provide examples of MR-based QIBs, describe key challenges to their disseminated implementation, and provide examples of approaches that a variety of agencies and organizations are taking to address those challenges.
This abstract and the presentation materials are available to members only; a login is required.